Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
185
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of CLTA-4 Gene Polymorphisms with Diabetes Mellitus: A Study Based on the Han Population of Northern China

Dongyue Ren1 Department of Emergency, the Fourth Affiliated Hospital of China Medical University, Shenyang, People’s Republic of ChinaView further author information
,
Lin He2 Good Clinical Practice Institution, the Fourth Affiliated Hospital of China Medical University, Shenyang, People’s Republic of ChinaView further author information
&
Xiaoling Pang1 Department of Emergency, the Fourth Affiliated Hospital of China Medical University, Shenyang, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 2705-2712 | Published online: 03 Sep 2022

References

  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14. doi:10.1016/j.diabres.2009.10.007
  • Cheng TO. Diabetes epidemic in China and its economic impact. Int J Cardiol. 2011;149:1–3. doi:10.1016/j.ijcard.2011.01.009
  • Ozougwu J, Obimba K, Belonwu C, Unakalamba C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathoph. 2013;4:46–57. doi:10.5897/JPAP2013.0001
  • Xie W, Burke B. Nuclear lamins and diabetes mellitus. STEMedicine. 2020;2:e73. doi:10.37175/stemedicine.v2i5.73
  • Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16:349–362. doi:10.1038/s41574-020-0355-7
  • Aylward A, Chiou J, Okino M-L, Kadakia N, Gaulton KJ. Shared genetic risk contributes to type 1 and type 2 diabetes etiology. Hum Mol Genet. 2018. doi:10.1093/hmg/ddy314
  • Dajani R, Li J, Wei Z, et al. Genome-wide association study identifies novel type II diabetes risk loci in Jordan subpopulations. PeerJ. 2017;5:e3618. doi:10.7717/peerj.3618
  • Borysewicz-Sańczyk H, Sawicka B, Wawrusiewicz-Kurylonek N, et al. Genetic Association Study of IL2RA, IFIH1, and CTLA-4 polymorphisms with autoimmune thyroid diseases and type 1 diabetes. Front Pediatr. 2020;8. doi:10.3389/fped.2020.00481
  • Chikuma S. CTLA-4, an essential immune-checkpoint for T-cell activation. In: Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity; 2017:99–126.
  • Hosseini A, Gharibi T, Marofi F, Babaloo Z, Baradaran B. CTLA-4: from mechanism to autoimmune therapy. Int Immunopharmacol. 2020;80:106221. doi:10.1016/j.intimp.2020.106221
  • Mäurer M, Loserth S, Kolb-Mäurer A, et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1+ 49) alters T-cell activation. Immunogenetics. 2002;54:1–8. doi:10.1007/s00251-002-0429-9
  • Gunavathy N, Asirvatham A, Chitra A, Jayalakshmi M. Association of CTLA-4 and CD28 gene polymorphisms with type 1 diabetes in South Indian population. Immunol Invest. 2019;48:659–671. doi:10.1080/08820139.2019.1590395
  • Gorgi Y, Sfar I, Abdallah TB, et al. Ctla-4 exon 1 (+ 49) and promoter (− 318) gene polymorphisms in kidney transplantation. Transplant Proc. 2006;38:2303–2305. doi:10.1016/j.transproceed.2006.06.132
  • Lee YH, Choi SJ, Ji JD, Song GG. No association of polymorphisms of the CTLA-4 exon 1 (+ 49) and promoter (−318) genes with rheumatoid arthritis in the Korean population. Scand J Rheumatol. 2002;31:266–270. doi:10.1080/030097402760375142
  • Angel B, Balic I, Santos JL, Codner E, Carrasco E, Pérez-Bravo F. Associations of the CTLA-4 polymorphisms with type 1 diabetes in a Chilean population: case-parent design. Diabetes Res Clin Pract. 2009;85:e34–e6. doi:10.1016/j.diabres.2009.05.019
  • Almasi S, Aliparasti MR, Aliasgarzadeh A, et al. Investigation of CTLA-4-318C/T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran. Immunol Lett. 2015;166:134–139. doi:10.1016/j.imlet.2015.05.021
  • Mojtahedi Z, Omrani GR, Doroudchi M, Ghaderi A. CTLA-4+ 49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes Res Clin Pract. 2005;68:111–116. doi:10.1016/j.diabres.2004.08.008
  • Mosaad YM, Elsharkawy AA, El-Deek BS. Association of CTLA-4 (+ 49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children. Immunol Invest. 2012;41:28–37. doi:10.3109/08820139.2011.579215
  • Mochizuki M, Amemiya S, Kobayashi K, et al. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care. 2003;26:843–847. doi:10.2337/diacare.26.3.843
  • Haller K, Kisand K, Nemvalts V, Laine AP, Ilonen J, Type UR. 1 diabetes is insulin− 2221 MspI and CTLA‐4+ 49 A/G polymorphism dependent. Eur J Clin Invest. 2004;34:543–548. doi:10.1111/j.1365-2362.2004.01385.x
  • Hinke SA. Diamyd, an alum-formulated recombinant human GAD65 for diabetes and the prevention of autoimmune diabetes. Curr Opin Mol Ther. 2008;10:1–10.
  • Mollo A, Hernandez M, Marsal JR, et al. Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain. Diabetes Metab Res Rev. 2013;29:446–451. doi:10.1002/dmrr.2411
  • Dong F, Yang G, Pan H-W, et al. The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis. Acta Diabetol. 2014;51:691–703. doi:10.1007/s00592-014-0613-z

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.